
I’ve been watching the JPX monitoring list update every month since it launched in 2023, and what strikes me — sitting here in Tokyo where this story gets covered daily in Nikkei and Toyo Keizai — is how badly the English-language financial press has underestimated the 2026 enforcement cycle; the March 2026 compliance review is a genuine forcing function, not another polite suggestion, and I want to give you the exact data sources and screening steps to act on it before the re-rating window narrows.
Investment Thesis
Author’s View: Constructive | Fair Value Estimate (Author’s Model): Thesis-based — highest conviction in sub-1× PBR TSE Prime names with net cash > 20% of market cap and a specific numerical plan already filed
Last updated: May 2025
- Core thesis: TSE’s escalating enforcement cycle reaches a hard compliance gate in March 2026 — the first review cycle where non-responsive companies face formal naming and potential delisting review — creating a deadline-driven re-rating catalyst that foreign investors can front-run using JPX’s publicly updated monitoring list.
- Numeric backing: Approximately 40% of TSE Prime constituents still traded below 1.0× PBR as of late 2024; median PBR has risen from ~1.1× (March 2023) to ~1.4× (2024), with further upside if laggards comply.
- Top risk: Compliance theater — companies may file qualitative “plans” that satisfy disclosure rules without committing to numerical targets, capping re-rating potential for the laggard cohort.
| Reform Metric | Data Point |
|---|---|
| TSE Prime constituents below 1.0× PBR (late 2024) | ~40% |
| TSE Prime median PBR (March 2023) | ~1.1× |
| TSE Prime median PBR (2024) | ~1.4× |
| ROE threshold triggering TSE review | < 8% |
| PBR threshold triggering TSE review | < 1.0× |
| First formal compliance gate | March 2026 |
| Activist ownership threshold (screening filter) | ≥ 5% via 大量保有報告書 |
The TSE reform story is one of the most consequential structural shifts in Japanese equities in a generation — and most English-language investors are still reading the 2023 headlines rather than the 2026 enforcement reality. This framework article walks through the timeline, the universe, the screening tools, and the macro context so you can build a repeatable process before the compliance window closes.
Disclosure: This article is for informational purposes only and does not constitute investment advice. See the full Disclaimer at the end of this article.
Why 2026 Is the Real Deadline, Not 2023
Most coverage of TSE’s capital-efficiency push treats March 2023 as the pivotal moment. It was important — but it was a request, not a requirement. The 2026 review cycle is where the enforcement ladder reaches its first hard rung.
From “Request” to “Requirement” — the Three-Phase TSE Enforcement Ladder
In March 2023, TSE sent a formal “Request for Action” letter to every TSE Prime and Standard-listed company trading below 1.0× PBR or generating ROE below 8%. The letter asked management to publicly disclose their awareness of the cost-of-capital gap and outline a plan to close it.
Phase one (2023–2024) was voluntary disclosure. TSE published a monthly 公表状況リスト (disclosure status monitoring list) tracking which companies had filed a plan, which were “under consideration,” and which had not responded at all.
Phase two (2024–2025) introduced naming. TSE began publicly identifying non-responsive companies in its quarterly updates, creating reputational pressure on laggard management teams — a meaningful escalation in Japan’s consensus-oriented corporate culture.
Phase three — the March 2026 compliance review — is the first formal gate. TSE has indicated it will escalate non-responsive companies to a delisting review process if no credible plan has been filed. That is a qualitatively different enforcement lever than public naming.
What the 2026 Compliance Review Actually Measures
A critical nuance: the 2026 review measures disclosure of a plan, not execution of one. TSE is not yet requiring companies to have achieved PBR > 1× by March 2026.
This creates both an opportunity and a risk. The opportunity: companies that have filed credible, numerical plans but not yet been re-rated represent the highest-conviction window. The risk: companies that file boilerplate qualitative plans can technically pass the 2026 gate without delivering real capital returns.
The distinction between disclosure compliance and execution compliance is the single most important concept for investors applying this framework.
How the JPX Monitoring List Is Updated and Where to Find It
JPX updates the 公表状況リスト monthly on its Japanese-language IR portal under the section titled “上場会社における資本コストや株価を意識した経営の実現に向けた対応について.” The list is a downloadable Excel file categorized by company name, ticker, market segment, and disclosure status.
English-language financial media rarely links to or parses this list directly. Investors who access it monthly gain a 4–6 week information edge over consensus, because plan filings and status upgrades show up here before they appear in English-language sell-side research or news wires.
Bookmark the JPX page and set a calendar reminder for the first week of each month when the updated list is typically published. This single habit puts you ahead of the majority of non-Japanese-reading foreign investors.
Mapping the Universe — Which Companies Face the Most Pressure
Understanding the timeline is only useful if you know which companies are on the clock. The reform target universe is large — but it is not evenly distributed across sectors.
Sector Heat Map — Where Sub-1× PBR Clusters Are Densest
Approximately 40% of TSE Prime constituents still traded below 1.0× PBR as of late 2024, based on JPX aggregate data. That is a substantial cohort — roughly 800+ companies — but the distribution is heavily skewed toward specific sectors.
Financials — particularly regional banks and mid-tier insurance companies — are the most overrepresented segment. Regional banks structurally struggle with sub-8% ROE in a low-rate environment, and many carry large cross-shareholding portfolios that suppress capital efficiency.
Industrials, construction, and trading companies are the next largest cluster. These sectors often carry substantial net cash positions and legacy cross-shareholdings accumulated over decades of keiretsu relationships — exactly the balance sheet inefficiency TSE reform is designed to address.
Think of this universe as the Japanese equivalent of a US value screen for cash-heavy industrials trading below book — except the catalyst here is regulatory, not purely market-driven, which makes the re-rating timeline more predictable.
Cross-Shareholding Unwind as the Hidden ROE Lever
政策保有株式 (seisaku hoyuu kabushiki — strategic cross-shareholdings) remain the single largest structural drag on ROE across the reform target universe. These are equity stakes that companies hold in business partners, suppliers, or customers for relationship purposes rather than investment returns.
METI’s revised engagement guidelines and the FSA’s Stewardship Code monitoring framework explicitly target cross-shareholding reduction as a priority. When a company sells these stakes, it simultaneously reduces its asset base (improving ROE) and generates cash that can be returned to shareholders via buybacks or dividends.
The cross-shareholding unwind is a multi-year process, not a single event. Companies that have already announced specific reduction schedules with named counterparties are further along the re-rating path than those with generic “we intend to reduce” language.
TSE Standard vs. TSE Prime — Different Pressure, Same Direction
TSE Standard-listed companies face a softer version of the same reform pressure. The monitoring list covers Standard companies, but the delisting-review escalation path is less clearly defined for Standard than for Prime.
For small-cap value investors, TSE Standard names can offer even deeper discount-to-book valuations with less institutional coverage — but the re-rating catalyst is less time-bound than in Prime. Size your Standard exposure accordingly: higher potential upside, longer and less predictable timeline.
Anatomy of a Credible Capital-Allocation Plan
Knowing who is under pressure is step one. Step two is distinguishing genuine reform commitments from compliance theater — and TSE has given investors an unofficial grading rubric to do exactly that.
TSE’s Four-Point Disclosure Checklist
TSE’s disclosure framework requires companies to address four elements in their capital-efficiency plans: (1) explicit acknowledgment of their cost of capital and the gap to current returns; (2) specific numerical targets for ROE, PBR, or ROIC; (3) a timeline for achieving those targets; and (4) concrete measures — buybacks, dividend policy changes, asset sales, or cross-shareholding reduction schedules.
TSE has published a 好事例集 (good disclosure examples document) on its IR portal — available in Japanese at the JPX capital-cost improvement page. This document functions as an unofficial scoring rubric. It shows, with real company examples, what “good” looks like across each of the four disclosure dimensions.
English-only investors are almost entirely unaware this document exists. Cross-referencing a company’s IR disclosure against the 好事例集 takes roughly 30 minutes per company and can reveal whether management is genuinely engaging or simply copy-pasting from a template.
Red Flags That Signal Boilerplate Compliance
Certain language patterns in capital-efficiency disclosures are reliable signals of low-conviction compliance. Watch for: “we aim to improve capital efficiency over the medium term” with no numerical target attached; ROE targets stated as ranges rather than floors (“ROE of 8–10%” vs. “ROE above 8% by FY2026”); and cross-shareholding reduction stated as a policy goal without a schedule or named counterparties.
Conversely, credible plans typically include: buyback authorization of at least 3% of shares outstanding with a specific execution timeline; dividend payout ratio guidance of 40% or higher with a multi-year commitment; and an explicit cross-shareholding reduction schedule with year-by-year targets and named counterparties where possible.
The quantitative specificity threshold is the clearest signal. Vague language is cheap; numerical commitments with timelines create accountability.
Using 大量保有報告書 Filings on EDINET as an Activist Early-Warning Signal
When an activist fund accumulates a stake of 5% or more in a Japanese company, it must file a 大量保有報告書 (large shareholding report) on EDINET, the FSA’s electronic disclosure system. These filings are public and searchable — but they are in Japanese and have no standardized English translation.
Activist funds including Oasis Management, Elliott, and ValueAct have been active in Japan. A new 大量保有報告書 filing from a known activist is one of the most reliable leading indicators that a specific company will face accelerated capital-allocation pressure — often 6–12 months before the story appears in English-language media.
EDINET’s search interface allows filtering by filing type (大量保有報告書) and date range. Setting a weekly search alert for this filing type across your watchlist companies is a straightforward process that most non-Japanese-reading investors skip entirely.
A Four-Step Screening Framework for Foreign Investors
With the evaluation criteria established, here is the repeatable screening process — built entirely from free, publicly available Japanese data sources that any investor with a browser can access.
Step 1–2: Building the Raw Watchlist from JPX and EDINET
Step 1: Download the current JPX monitoring list from the JPX capital-cost improvement portal. Filter for companies with status “未対応” (no plan filed) or “検討中” (under consideration). These are the highest-pressure names — they face the most acute 2026 deadline risk and therefore the most compressed re-rating timeline once a credible plan is filed.
Step 2: Cross-reference each name on EDINET for the latest 有価証券報告書 (annual securities report). Within the report, locate the 政策保有株式の縮減方針 (cross-shareholding reduction policy) section and the balance sheet for net cash position. Record PBR, ROE (trailing), and whether a specific cross-shareholding reduction schedule is disclosed.
This two-step process gives you a raw watchlist of companies that are (a) under the most regulatory pressure and (b) have quantifiable balance sheet optionality. You can use TradingView’s screener to pre-filter TSE stocks by PBR < 1 before cross-referencing with the JPX list — it saves time when working through a large initial universe.
Step 3–4: Filtering for Activist Catalysts and Disclosure Quality
Step 3: Search EDINET’s 大量保有報告書 database for each watchlist company. Filter for filings disclosing ownership of 5% or more by a known activist fund within the past 12 months. Companies with activist ownership already on the register have an external pressure agent accelerating management’s response — this is a meaningful catalyst differentiator.
Step 4: Evaluate IR disclosure quality against TSE’s 好事例集 rubric. Score each company on three dimensions: (a) does the plan include a specific numerical ROE or PBR target with a deadline? (b) does it include a concrete capital return measure — buyback authorization, dividend payout ratio floor, or cross-shareholding reduction schedule? (c) is the language specific enough to create management accountability if unmet?
Companies scoring high on Step 4 with activist presence from Step 3 represent the highest-conviction sub-universe — they have both external pressure and a credible internal commitment.
Applying the Net-Cash / PBR Torque Filter to Rank Candidates
The final ranking filter is balance sheet optionality. Companies where net cash exceeds 20% of market capitalization AND PBR is below 1.0× represent the highest-torque re-rating candidates.
The logic: if a company holds net cash worth 25% of its market cap, it could theoretically return that cash via a special dividend or buyback and immediately compress the PBR gap — without any operational improvement. When regulatory pressure forces management’s hand, the re-rating can be rapid and substantial.
This is conceptually similar to a US net-net value screen, but with the added catalyst of a regulatory deadline. The combination of deep discount, cash optionality, and a hard compliance date is unusual in developed markets — it is the core reason Japan’s reform story remains compelling for value-oriented foreign investors even after the 2023–2024 re-rating.
For US investors building a Japan allocation within an IRA or taxable account, this screened sub-universe — sub-1× PBR, net cash > 20% of market cap, numerical plan filed, activist presence — functions as a higher-conviction alternative to a broad Japan ETF. The ETF gives you beta to the reform theme; the screened sub-universe gives you alpha potential from individual re-ratings. Both have a role depending on your position-sizing philosophy. For context, a broad Japan ETF like EWJ or DXJ gives you passive exposure, but it also dilutes you across the many companies that will file boilerplate plans and underperform.
Currency, Macro, and BOJ Policy as Reform Amplifiers or Dampeners
The TSE reform story does not exist in a macro vacuum. BOJ normalization, yen trajectory, and foreign fund flows all affect how quickly and how much the re-rating materializes.
BOJ Normalization as a Structural Accelerant for Capital Efficiency Reform
BOJ’s exit from yield curve control (YCC) and its 2024 rate hikes — documented in the quarterly 展望レポート (Outlook Report) — raise the risk-free rate in Japan. This has a direct and underappreciated effect on TSE reform compliance urgency.
When the risk-free rate was near zero, holding large cash balances or low-return cross-shareholdings had minimal opportunity cost. As rates normalize, the cost of capital rises — and the gap between a company’s actual ROE and its cost of equity becomes more visible and more painful for management to defend.
BOJ normalization and TSE reform are therefore complementary accelerants. Higher rates make zero-return cash hoards more costly to defend, which strengthens the argument for buybacks and cross-shareholding unwinds — exactly what the reform framework demands.
The BOJ’s 展望レポート is published in Japanese first, with the English translation typically delayed by one to two weeks. Investors who read the Japanese version directly gain forward guidance on corporate sector financial conditions — and therefore on cost-of-capital assumptions — before the English-language consensus has processed it.
Yen Sensitivity — How Currency Moves Distort or Amplify Reform-Driven ROE Gains
Yen weakness (円安) flatters reported ROE for export-heavy companies by inflating yen-denominated earnings without any structural improvement in capital efficiency. This creates a measurement problem: a company’s ROE may appear to be improving when the driver is currency translation rather than genuine reform execution.
Conversely, yen strength (円高) compresses export-sector earnings and can mask genuine ROE improvement from operational reform. For US-based investors, yen moves also affect the USD-denominated return on any Japan equity position — a 10% yen depreciation erases a 10% equity gain in USD terms.
The practical implication: when evaluating reform-driven ROE improvement, strip out the currency effect by looking at ROE on a constant-currency basis or focusing on domestic-demand sectors (financials, construction, services) where yen translation effects are minimal. These sectors also happen to be the most overrepresented in the sub-1× PBR universe — a useful alignment.
For position sizing, US investors should treat JPY/USD as a secondary variable. The reform re-rating thesis is a multi-year structural story; short-term yen volatility should inform position sizing and hedging decisions, not whether to participate at all. Unhedged positions in domestic-demand names give you both the reform re-rating and potential yen appreciation as BOJ normalization proceeds — a dual tailwind scenario worth considering.
Risks and Counter-View — Where the Reform Thesis Can Break Down
The reform thesis is compelling, but it carries three specific risks that investors must price before sizing positions. These are not generic disclaimers — they are structural vulnerabilities in the enforcement mechanism itself.
Risk 1 — Compliance Theater at Scale
TSE’s enforcement mechanism is disclosure-based, not outcome-based. A company can file a plan stating “we aim to improve PBR over the medium term through ongoing capital efficiency initiatives” with no numerical target and technically satisfy the 2026 disclosure requirement.
Early JPX monitoring data from 2024 showed a meaningful share of “plan filed” companies offered only qualitative commitments. If the majority of laggards pursue this path, the re-rating catalyst for the broader cohort evaporates — and investors who bought the theme rather than individual high-conviction names will be disappointed.
This is why the four-step screening framework above — specifically Step 4’s disclosure quality evaluation — is essential. The theme-level re-rating may be limited; the individual-name re-rating for companies with credible, numerical plans can still be substantial.
Risk 2 — Cross-Shareholding Unwind Creates Structural Selling Pressure
As companies reduce 政策保有株式, they become net sellers of Japanese equities. If cross-shareholding unwinding accelerates simultaneously across the financial and industrial sectors — which are both the largest holders and the most reform-pressured — it creates a structural supply overhang that can offset buyback demand.
This risk is most acute in financials, where regional banks and insurance companies hold substantial cross-shareholding portfolios. The unwinding is a positive for the selling company’s ROE, but it is a headwind for the broader market and for the specific companies whose shares are being sold.
Monitor the pace of cross-shareholding reduction disclosures in 有価証券報告書 filings on EDINET. If multiple large holders announce accelerated unwind schedules simultaneously, it is worth reducing broad sector exposure and concentrating in names that are net beneficiaries (sellers) rather than net victims (companies whose shares are being sold).
Risk 3 — Activist Fatigue and Management Entrenchment
Japanese corporate governance reform has been declared “imminent” multiple times since the Abe-era Stewardship Code of 2014. Management teams now have a decade of experience deflecting activist pressure with procedural responses — filing plans, holding engagement meetings, and making incremental concessions that satisfy disclosure requirements without delivering transformative capital returns.
The 2026 deadline is a harder forcing function than anything in the 2014–2023 cycle. But it is not immune to procedural compliance. Domestic Japanese institutional investors — life insurance companies and trust banks — publish annual スチュワードシップ活動報告 (stewardship activity reports) in Japanese that reveal how Japan’s largest shareholders are actually voting on capital-allocation proposals. These reports are the ground-level read on whether reform pressure is genuine or performative.
If domestic institutions are consistently voting in favor of management on capital-return proposals despite sub-1× PBR, the activist pressure from foreign funds alone is unlikely to force behavioral change. Conversely, if domestic stewardship reports show increasing opposition votes on capital-allocation resolutions, that is a meaningful signal that the reform cycle has genuine momentum.
For related analysis on how to identify which TSE Prime companies are already raising dividends under reform pressure, see Why U.S. Investors Need Japan’s 2.5% Yields (TSE 2026) — it covers the dividend growth angle of the same reform dynamic.
Bottom Line — How to Position for the 2026 Compliance Catalyst
The March 2026 compliance review is the most concrete forcing function in Japan’s corporate governance reform cycle since the Stewardship Code’s introduction. Unlike most Japan reform narratives — which have historically been directionally correct but indefinitely timed — this one has a calendar date attached to a specific enforcement escalation.
The highest-conviction positioning is narrow and specific: TSE Prime companies with sub-1× PBR, net cash exceeding 20% of market cap, activist ownership of 5% or more already on the register, and a capital-efficiency plan that includes specific numerical targets and timelines. This intersection of balance sheet optionality, external pressure, and credible internal commitment is where the re-rating timeline is most compressed.
Avoid the broad “plan filed” cohort without further filtering. Companies with qualitative-only disclosures face the compliance theater risk and are unlikely to deliver the re-rating that the theme implies. The JPX monitoring list tells you who filed; the 好事例集 rubric tells you whether what they filed is worth anything.
Position sizing should reflect the 12–24 month re-rating horizon. This is not a 3-month catalyst trade — it is a structural theme with a known deadline that creates a series of individual re-rating events as companies move from “plan filed” to “execution visible.” Size accordingly: meaningful enough to matter to your portfolio, small enough that yen volatility and compliance-theater disappointments do not force you out of a position before the thesis plays out.
For a deeper dive into specific TSE Prime names that screen well on these criteria, see How U.S. Investors Can Target Sub-1× PBR Japan Stocks (2026) — it applies the framework above to a curated list of reform candidates with individual company analysis.
Between now and March 2026, monitor three data streams: the JPX monitoring list (monthly, for status changes from “未対応” to “plan filed”); EDINET 大量保有報告書 filings (weekly, for new activist accumulation); and BOJ 展望レポート releases (quarterly, for cost-of-capital trajectory). These three sources, read in Japanese, give you a materially earlier read on reform momentum than any English-language news flow.
Frequently Asked Questions
Q: What exactly happens to a TSE Prime company that does not file a capital-efficiency plan by the March 2026 deadline?
TSE has indicated that non-responsive companies — those that have neither filed a plan nor demonstrated engagement with the disclosure framework — will be escalated to a formal compliance review process that can ultimately lead to delisting review. This is a qualitatively different enforcement level from the public naming used in 2024. However, the delisting process in Japan is slow and multi-step; the more immediate consequence is reputational damage and intensified activist attention, which can be a more powerful short-term catalyst than the regulatory process itself.
Q: How do I access the JPX monitoring list and EDINET as a US-based investor with no Japanese reading ability?
Both sites are accessible from any browser globally. The JPX monitoring list is a downloadable Excel file — the column headers are in Japanese, but the company names and tickers are in standard format, and the status categories (未対応, 検討中, 対応済) can be identified by their position in the file. EDINET filings include the company’s securities code, which cross-references directly with TSE tickers. Google Translate’s document translation feature handles Excel and PDF files reasonably well for initial screening — it will not give you a perfect translation, but it is sufficient to identify the key data fields described in the four-step framework above.
Q: What is the withholding tax treatment for Japanese dividends in a US IRA account?
Under the US-Japan tax treaty, Japanese dividend withholding is 15% for US residents. In a taxable account, this 15% withholding is generally claimable as a foreign tax credit on IRS Form 1116. In a traditional IRA, the foreign tax credit cannot be claimed — the 15% withholding is a permanent cost. In a Roth IRA, the same limitation applies. For tax-sensitive US investors, this makes Japan equity exposure in a taxable account more efficient than in a tax-advantaged account, unless the broker can negotiate treaty reclaim procedures. Consult your tax advisor for your specific situation.
Q: Is the TSE reform thesis already “priced in” after the 2023–2024 re-rating?
Partially. The median TSE Prime PBR has risen from approximately 1.1× to 1.4× since March 2023, reflecting the market’s initial pricing of the reform narrative. However, approximately 40% of TSE Prime constituents still traded below 1.0× PBR as of late 2024 — meaning the re-rating has been concentrated in early movers and high-profile names. The laggard cohort, particularly in regional financials and mid-cap industrials, has not yet re-rated. The 2026 deadline creates a second wave of catalysts specifically for this laggard cohort. The theme is partially priced; the individual-name opportunity in credible-plan laggards is not.
Q: How do I track Japanese stocks in my screening workflow without a Bloomberg terminal?
TradingView’s screener supports TSE-listed stocks with PBR, ROE, and market cap filters — it is a practical starting point for building an initial universe before cross-referencing with the JPX monitoring list. The JPX itself also provides free screening tools on its website. For 大量保有報告書 and 有価証券報告書 filings, EDINET is free and requires no subscription. The combination of TradingView for initial quantitative screening and EDINET for qualitative document review covers the full four-step framework without any paid data service.
How to Access TSE-Listed Stocks as an International Investor
The TSE reform framework described in this article applies to stocks listed on the Tokyo Stock Exchange Prime and Standard markets. There are no ADR programs for the broad TSE reform universe — direct TSE access is required to implement the four-step screening framework.
International investors can access TSE-listed stocks directly through:
- Saxo Bank — full TSE coverage, available in Singapore, Japan, Europe, and most countries. Strong platform for Japan equity access. Preferred broker for our Singapore/Asia-based readers.
- Interactive Brokers (IBKR) — direct TSE access, competitive JPY/USD spread, available in US and most countries. Strong choice for US-based investors implementing the screening framework described above.
- Webull — lower minimums, growing TSE coverage, good for smaller position sizes (US audience).
Tax notes by country:
- Singapore: No capital gains tax on Japan stocks. Japanese dividends are subject to 20.315% withholding (15% when the Japan-Singapore tax treaty applies via your broker). Net dividend received after withholding — check with your broker on treaty reclaim procedures.
- United States: Japanese dividend withholding is 15% under the US-Japan tax treaty; claimable as a foreign tax credit on IRS Form 1116 in a taxable account. IRA holders cannot claim the foreign tax credit — the 15% withholding is a permanent cost in tax-advantaged accounts.
- Other countries: Withholding rates vary by treaty. Check Japan’s National Tax Agency treaty list or consult your broker.
Account opening eligibility varies by country of residence. I am not affiliated with these brokers; this is general information only. Always verify current terms directly with the broker.
Disclaimer: This article is published for informational and educational purposes only and does not constitute investment advice or a solicitation to buy or sell any security. Opinions expressed are my own and do not represent the views of any financial institution. I may or may not hold positions in the securities or instruments discussed in this article. All investments involve risk, including the possible loss of principal. Past performance is not indicative of future results. This disclosure is made in accordance with FTC 16 CFR Part 255 regarding the use of endorsements and testimonials. Japanese equity investments carry additional risks including currency risk (JPY/USD fluctuation), regulatory risk, and liquidity risk for smaller-cap names. Nothing in this article should be construed as an investment recommendation. Always conduct your own due diligence and consult a qualified financial advisor before making investment decisions. As of May 2025. Full Disclaimer.